Bitome

company

About

Bitome offers noninvasive Dx tools for real-time volume status monitoring.

  • 1 - 10

Details

Last Funding Type
Seed
Industries
Biometrics,Biotechnology,Health Diagnostics,Medical Device
Founded date
Mar 31, 2016
Number Of Employee
1 - 10
Operating Status
Active

Bitome is a two-year-old, Boston-based connected med device company. Its first product is a noninvasive tool for monitoring hydration status with broad applications across the dialysis, diabetic, sports performance, and maternal / fetal monitoring spaces. In a first application, Bitome’s technology will precisely assess volume status in congestive heart failure (CHF) patients – a key, but hard to measure, biometric correlated with patient outcomes. In short, Bitome wants to use hydration monitoring technology to do for CHF, what glucose monitoring has done for diabetes.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
4
$225K
Bitome has raised a total of $225K in funding over 2 rounds. Their latest funding was raised on May 6, 2020 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
May 6, 2020 Grant $225K 1 National Science Foundation Detail
Mar 28, 2018 Convertable Note 1 Detail
Oct 17, 2016 Convertable Note 1 Detail
Aug 24, 2016 Seed 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
2
Bitome is funded by 2 investors. National Science Foundation and HAX are the most recent investors.
Investor Name Lead Investor Funding Round
National Science Foundation Yes Grant
HAX Convertable Note